Verici Dx plc (LON:VRCI – Get Free Report)’s share price traded down 13.3% on Friday . The stock traded as low as GBX 3.25 ($0.04) and last traded at GBX 3.25 ($0.04). 118,928 shares traded hands during mid-day trading, a decline of 83% from the average session volume of 688,850 shares. The stock had previously closed at GBX 3.75 ($0.05).
Verici Dx Stock Down 14.7 %
The company has a market cap of £7.76 million, a PE ratio of -160.00 and a beta of 1.59. The stock has a 50-day moving average of GBX 3.58 and a 200-day moving average of GBX 4.92. The company has a quick ratio of 8.49, a current ratio of 4.54 and a debt-to-equity ratio of 4.65.
About Verici Dx
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
Featured Stories
- Five stocks we like better than Verici Dx
- Ride Out The Recession With These Dividend Kings
- Price Plunge in Roblox Presents Opportunity for Robust Gains
- The How and Why of Investing in Gold Stocks
- Billions in Buybacks: 4 Stocks Rewarding Shareholders Now
- Find and Profitably Trade Stocks at 52-Week Lows
- 3 Steel Stocks to Gain Strength as Tariffs Reshape the Market
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
